Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Robert L. Nussbaum net worth and biography

Robert Nussbaum Biography and Net Worth

Insider of Invitae

Dr. Nussbaum has served as Invitae’s Chief Medical Officer since August 2015.
Prior to joining Invitae, he was chief of the Division of Genomic Medicine at UCSF Health, where he also held leadership roles in the Cancer Genetics and Prevention Program beginning in January 2009 and the Program in Cardiovascular Genetics beginning in July 2007. From April 2006 to August 2015, he served as a member of the UCSF Institute for Human Genetics.
Prior to joining UCSF Health, Dr. Nussbaum was chief of the Genetic Disease Research Branch of the National Human Genome Research Institute, one of the National Institutes of Health, from 1994 to 2006.
He is a member of the Institute of Medicine and a fellow at the American Academy of Arts and Sciences.
Dr. Nussbaum is a board-certified internist and medical geneticist who holds a B.S. in Applied Mathematics from Harvard College and an M.D. from Harvard Medical School in the Harvard-MIT joint program in Health Sciences and Technology.
He completed his residency in internal medicine at Barnes-Jewish Hospital and a fellowship in medical genetics at the Baylor College of Medicine.

What is Robert L. Nussbaum's net worth?: The estimated net worth of Robert L. Nussbaum is at least $1,138.69 as of June 13th, 2023. Mr. Nussbaum owns 569,345 shares of Invitae stock worth more than $1,139 as of April 18th. This net worth approximation does not reflect any other investments that Mr. Nussbaum may own. Learn More about Robert L. Nussbaum's net worth.
How do I contact Robert L. Nussbaum?: The corporate mailing address for Mr. Nussbaum and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected]. Learn More on Robert L. Nussbaum's contact information.
Has Robert L. Nussbaum been buying or selling shares of Invitae?: Robert L. Nussbaum has not been actively trading shares of Invitae in the last ninety days. Most recently, Robert L. Nussbaum sold 7,086 shares of the business's stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $1.38, for a transaction totalling $9,778.68. Following the completion of the sale, the insider now directly owns 569,345 shares of the company's stock, valued at $785,696.10. Learn More on Robert L. Nussbaum's trading history.
Who are Invitae's active insiders?: Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.
Are insiders buying or selling shares of Invitae?: During the last year, insiders at the medical research company sold shares 5 times. They sold a total of 144,005 shares worth more than $208,408.56. The most recent insider tranaction occured on June, 13th when insider Robert L Nussbaum sold 7,086 shares worth more than $9,778.68. Insiders at Invitae own 0.7% of the company. Learn More about insider trades at Invitae.
Information on this page was last updated on 6/13/2023.

Robert L. Nussbaum Insider Trading History at Invitae

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/13/2023	Sell	7,086	$1.38	$9,778.68	569,345
5/16/2023	Sell	26,476	$1.20	$31,771.20	576,431
3/14/2022	Sell	19,588	$6.69	$131,043.72
11/11/2021	Sell	29,675	$21.89	$649,585.75
8/16/2021	Sell	21,231	$25.42	$539,692.02
3/12/2021	Sell	18,159	$42.90	$779,021.10
9/10/2020	Sell	23,175	$33.56	$777,753.00
7/9/2020	Sell	29,783	$34.15	$1,017,089.45
5/22/2020	Sell	19,893	$17.28	$343,751.04
5/20/2020	Sell	6,864	$16.70	$114,628.80
8/19/2019	Sell	20,447	$25.29	$517,104.63
5/20/2019	Sell	7,202	$18.21	$131,148.42
1/10/2019	Sell	5,222	$14.01	$73,160.22
5/15/2018	Sell	6,702	$6.96	$46,645.92
2/15/2017	Sell	1,686	$9.53	$16,067.58	62,823

Robert L. Nussbaum Buying and Selling Activity at Invitae

Invitae Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Today's Range

Now: $0.00

$0.00

$0.01

50 Day Range

MA: $0.02

$0.00

$0.09

2 Week Range

Now: $0.00

$0.02

Volume

139,935 shs

Average Volume

23,716,614 shs

Market Capitalization

$534,020.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad